Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns

Keyphrases

• Safety Concerns 100%
• Antipsychotics 100%
• Adverse Effects 66%
• Second-generation Antipsychotics 66%
• Clinically Significant 33%
• High Risk 33%
• Tolerability 33%
• Long-term Treatment 33%
• Safety Data 33%
• Treatment Choice 33%
• Efficacy Data 33%
• Psychosis 33%
• Expert Panel 33%
• Metabolic Abnormalities 33%
• Safety Profile 33%
• Induced Toxicity 33%
• Treatment Strategy 33%
• Aggression 33%
• Study Support 33%
• Diagnostic Categories 33%
• Endocrine Abnormalities 33%
• Risk-benefit Ratio 33%
• Short-term Efficacy 33%
• Mania 33%
• Acute Treatment 33%
• Preventive Strategies 33%
• Extrapyramidal Symptoms 33%
• Safety Considerations 33%
• Clozapine 33%
• Neuropsychopharmacology 33%
• Intermediate Care 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Typical Antipsychotic 100%
• Adverse Event 66%
• Antipsychotic 66%
• Tolerability 33%
• Psychopharmacology 33%
• Clozapine 33%
• Extrapyramidal Symptoms 33%